Literature DB >> 31587181

Dual-source dual-energy CT in the evaluation of hepatic fractional extracellular space in cirrhosis.

Antonio Bottari1, Salvatore Silipigni2, Maria Ludovica Carerj1, Antonino Cattafi1, Sergio Maimone3, Maria Adele Marino1, Silvio Mazziotti1, Alessia Pitrone1, Giovanni Squadrito3, Giorgio Ascenti1.   

Abstract

BACKGROUND: One of the main features of liver fibrosis is the expansion of the interstitial space. All water-soluble CT contrast agents remain confined in the vascular and interstitial space constituting the fractional extracellular space (fECS). Indirect measure of its expansion can be quantified during equilibrium phase with CT. The goal of this prospective study was to assess the feasibility of dual-energy CT (DECT) with iodine quantification at equilibrium phase in the evaluation of significant fibrosis or cirrhosis.
METHODS: Thirty-eight cirrhotic patients (according to Child-Pugh and MELD scores), scheduled for liver CT, were enrolled in the study group. Twenty-four patients undergoing CT urography with a 10-min excretory phase were included in the control group. fECS was calculated as the ratio of the iodine concentration of liver parenchyma to that of the aorta, multiplied by 1 minus hematocrit.
RESULTS: Final study and control group were, respectively, composed of 22 and 20 patients. Mean hepatic fECS value was statistically greater in study group (P < 0.05). Positive correlation was observed between hepatic fECS value and MELD score (r = 0.64, P < 0.05). Analysis of variance showed statistical differences between control group and the Child-Pugh grades and between Child-Pugh A and B patients and Child-Pugh C patients (P < 0.05). ROC curves analysis yielded an optimum fECS cutoff value of 26.3% for differentiation of control group and cirrhotic patients (AUC 0.88; 86% sensitivity, 85% specificity).
CONCLUSIONS: Dual-source DECT is a feasible, noninvasive method for the assessment of significant liver fibrosis or cirrhosis.

Entities:  

Keywords:  Dual-energy CT; Dual-source; Fibrosis—cirrhosis; Iodine concentration—fractional extracellular space

Mesh:

Year:  2019        PMID: 31587181     DOI: 10.1007/s11547-019-01089-7

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  29 in total

1.  Effect of a Noise-Optimized Second-Generation Monoenergetic Algorithm on Image Noise and Conspicuity of Hypervascular Liver Tumors: An In Vitro and In Vivo Study.

Authors:  Daniele Marin; Juan Carlos Ramirez-Giraldo; Sonia Gupta; Wanyi Fu; Sandra S Stinnett; Achille Mileto; Davide Bellini; Bhavik Patel; Ehsan Samei; Rendon C Nelson
Journal:  AJR Am J Roentgenol       Date:  2016-04-08       Impact factor: 3.959

Review 2.  Dual-Energy Computed Tomography: Physical Principles, Approaches to Scanning, Usage, and Implementation: Part 1.

Authors:  Reza Forghani; Bruno De Man; Rajiv Gupta
Journal:  Neuroimaging Clin N Am       Date:  2017-08       Impact factor: 2.264

3.  The clinical value of hepatic extracellular volume fraction using routine multiphasic contrast-enhanced liver CT for staging liver fibrosis.

Authors:  S L Guo; L N Su; Y N Zhai; W M Chirume; J Q Lei; H Zhang; L Yang; X P Shen; X X Wen; Y M Guo
Journal:  Clin Radiol       Date:  2016-10-26       Impact factor: 2.350

4.  Dual-energy CT with iodine quantification in distinguishing between bland and neoplastic portal vein thrombosis in patients with hepatocellular carcinoma.

Authors:  G Ascenti; C Sofia; S Mazziotti; S Silipigni; T D'Angelo; S Pergolizzi; E Scribano
Journal:  Clin Radiol       Date:  2016-05-27       Impact factor: 2.350

5.  Stratification of patients with liver fibrosis using dual-energy CT.

Authors:  Peter Lamb; Dushyant V Sahani; Jorge M Fuentes-Orrego; Manuel Patino; Asish Ghosh; Paulo R S Mendonça
Journal:  IEEE Trans Med Imaging       Date:  2014-08-28       Impact factor: 10.048

6.  Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT.

Authors:  Vanja Varenika; Yanjun Fu; Jacquelyn J Maher; Dongwei Gao; Sanjay Kakar; Miguel C Cabarrus; Benjamin M Yeh
Journal:  Radiology       Date:  2012-11-20       Impact factor: 11.105

Review 7.  Liver cirrhosis.

Authors:  Emmanuel A Tsochatzis; Jaime Bosch; Andrew K Burroughs
Journal:  Lancet       Date:  2014-01-28       Impact factor: 79.321

8.  How accurate and precise are CT based measurements of iodine concentration? A comparison of the minimum detectable concentration difference among single source and dual source dual energy CT in a phantom study.

Authors:  André Euler; Justin Solomon; Maciej A Mazurowski; Ehsan Samei; Rendon C Nelson
Journal:  Eur Radiol       Date:  2018-10-01       Impact factor: 5.315

9.  Water/cortical bone decomposition: A new approach in dual energy CT imaging for bone marrow oedema detection. A feasibility study.

Authors:  M Biondi; E Vanzi; G De Otto; F Banci Buonamici; G M Belmonte; L N Mazzoni; A Guasti; S F Carbone; M A Mazzei; A La Penna; E Foderà; D Guerreri; A Maiolino; L Volterrani
Journal:  Phys Med       Date:  2016-08-11       Impact factor: 2.685

10.  Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity.

Authors:  Maurice H Zissen; Zhen Jane Wang; Judy Yee; Rizwan Aslam; Alexander Monto; Benjamin M Yeh
Journal:  AJR Am J Roentgenol       Date:  2013-12       Impact factor: 3.959

View more
  15 in total

1.  Dual-energy CT quantification of fractional extracellular space in cirrhotic patients: comparison between early and delayed equilibrium phases and correlation with oesophageal varices.

Authors:  Giuseppe Cicero; Silvio Mazziotti; Salvatore Silipigni; Alfredo Blandino; Vito Cantisani; Stefano Pergolizzi; Tommaso D'Angelo; Alberto Stagno; Sergio Maimone; Giovanni Squadrito; Giorgio Ascenti
Journal:  Radiol Med       Date:  2021-03-14       Impact factor: 3.469

2.  Intrahepatic cholangiocarcinoma and its differential diagnosis at MRI: how radiologist should assess MR features.

Authors:  Vincenza Granata; Roberta Grassi; Roberta Fusco; Sergio Venanzio Setola; Andrea Belli; Alessandro Ottaiano; Guglielmo Nasti; Michelearcangelo La Porta; Ginevra Danti; Salvatore Cappabianca; Carmen Cutolo; Antonella Petrillo; Francesco Izzo
Journal:  Radiol Med       Date:  2021-11-29       Impact factor: 3.469

3.  Evaluation of liver fibrosis using hepatic extracellular volume fraction by contrast-enhanced computed tomography before and after direct-acting antiviral therapy in patients with chronic hepatitis C infection: comparison with serological liver fibrosis markers.

Authors:  Akihiko Kanki; Kiyoka Maeba; Hidemitsu Sotozono; Kazuya Yasokawa; Atsushi Higaki; Akira Yamamoto; Tsutomu Tamada
Journal:  Br J Radiol       Date:  2021-09-29       Impact factor: 3.039

Review 4.  Radiomics in medical imaging: pitfalls and challenges in clinical management.

Authors:  Roberta Fusco; Vincenza Granata; Giulia Grazzini; Silvia Pradella; Alessandra Borgheresi; Alessandra Bruno; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Andrea Giovagnoni; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2022-03-28       Impact factor: 2.701

Review 5.  Dual-energy CT in diffuse liver disease: is there a role?

Authors:  Khaled Y Elbanna; Bahar Mansoori; Achille Mileto; Patrik Rogalla; Luís S Guimarães
Journal:  Abdom Radiol (NY)       Date:  2020-08-08

Review 6.  Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging.

Authors:  Domenico Albano; Federico Bruno; Andrea Agostini; Salvatore Alessio Angileri; Massimo Benenati; Giulia Bicchierai; Michaela Cellina; Vito Chianca; Diletta Cozzi; Ginevra Danti; Federica De Muzio; Letizia Di Meglio; Francesco Gentili; Giuliana Giacobbe; Giulia Grazzini; Irene Grazzini; Pasquale Guerriero; Carmelo Messina; Giuseppe Micci; Pierpaolo Palumbo; Maria Paola Rocco; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2021-12-24       Impact factor: 2.374

7.  An update on radiomics techniques in primary liver cancers.

Authors:  Vincenza Granata; Roberta Fusco; Sergio Venazio Setola; Igino Simonetti; Diletta Cozzi; Giulia Grazzini; Francesca Grassi; Andrea Belli; Vittorio Miele; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2022-03-04       Impact factor: 2.965

8.  Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma.

Authors:  Vincenza Granata; Roberta Fusco; Andrea Belli; Valentina Borzillo; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Alessandro Ottaiano; Guglielmo Nasti; Vincenzo Pilone; Antonella Petrillo; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2022-03-28       Impact factor: 2.965

Review 9.  Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma.

Authors:  Vincenza Granata; Roberta Grassi; Roberta Fusco; Andrea Belli; Carmen Cutolo; Silvia Pradella; Giulia Grazzini; Michelearcangelo La Porta; Maria Chiara Brunese; Federica De Muzio; Alessandro Ottaiano; Antonio Avallone; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2021-07-19       Impact factor: 2.965

10.  Non-invasive assessment of cirrhosis using multiphasic dual-energy CT iodine maps: correlation with model for end-stage liver disease score.

Authors:  Domenico Mastrodicasa; Martin J Willemink; Celina Duran; Andrea Delli Pizzi; Virginia Hinostroza; Lior Molvin; Mohamed Khalaf; R Brooke Jeffrey; Bhavik N Patel
Journal:  Abdom Radiol (NY)       Date:  2020-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.